Julie Papanek Grant's Net Worth
$0
Who is Julie Papanek Grant?
Julie Papanek Grant does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., and Protagonist Therapeutics, Inc.
SEC CIK
Julie Papanek Grant's CIK is 0001673237
Past Insider Trading and Trends
2016 was Julie Papanek Grant's most active year for acquiring shares with 1 total transactions. Julie Papanek Grant's most active month to acquire stocks was the month of April. 2021 saw Julie Papanek Grant paying a total of $0.00 for 63,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.04% | -25.00K |
$18.61 | -$465,302.50 | 330K |
Scheduled
|
Mar 1
| ||
Form 4
| -6.58% | -25.00K |
$21.23 | -$530,794.33 | 355K |
Scheduled
|
Feb 1
| ||
Form 4
| -6.17% | -25.00K |
$20.65 | -$516,147.12 | 380K |
Scheduled
|
Jan 3
| ||
Form 4
| -1.06% | -4.36K |
$22.08 | -$96,210.26 | 405K |
Scheduled
|
Dec 8
| ||
Form 4
| -2.38% | -10.00K |
$21.65 | -$216,480.39 | 409.36K |
Scheduled
|
Dec 1 - Dec 2
| ||
Form 4
| -2.33% | -10.00K |
$20.03 | -$200,277.50 | 419.36K |
Scheduled
|
Nov 1 - Nov 2
| ||
Form 4
| -2.28% | -10.00K |
$20.03 | -$200,315.00 | 429.36K |
Scheduled
|
Oct 3 - Oct 4
| ||
Form 4
| -23.28% | -2.11M |
$18.55 |
—
| 6.96M |
Sep 21
| |||
Form 4
| -3.62% | -340.70K |
$20.44 | -$6,963,115.78 | 9.08M |
Sep 16 - Sep 20
| |||
Form 4
| -2.54% | -245.04K |
$23.76 | -$5,823,084.06 | 9.42M |
Sep 13 - Sep 15
| |||
Form 4
| -1.13% | -5.00K |
$23.82 | -$119,107.50 | 439.36K |
Scheduled
|
Sep 2
| ||
Form 4
| -1.11% | -5.00K |
$23.27 | -$116,358.38 | 444.36K |
Scheduled
|
Sep 1
| ||
Form 4
| -2.18% | -10.00K |
$20.00 | -$200,004.00 | 449.36K |
Scheduled
|
Aug 4 - Aug 5
| ||
Form 4
| -0.56% | -2.60K |
$20.00 | -$52,001.04 | 459.36K |
Scheduled
|
Jul 18
| ||
Form 4/A
| -0.39% | -1.80K |
$20.00 | -$36,000.00 | 463.2K |
Scheduled
|
Jul 1 - Jul 5
| ||
Form 4
| -0.27% | -1.24K |
$20.00 | -$24,840.00 | 461.96K |
Scheduled
|
Jul 8
| ||
Form 4
| -0.39% | -1.80K |
$20.00 | -$36,000.00 | 463.2K |
Scheduled
|
Jul 1 - Jul 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +230.75% | 7.49M |
$16.00 |
—
| 10.74M |
Feb 1 - Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $41.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
∞
| 2.45M |
$12.00 |
—
| 2.45M |
Aug 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||